US Broker Ratings

AstraZeneca PLC (AZN) Stock Analysis: Unveiling a 14.93% Potential Upside for Investors

AstraZeneca PLC (AZN), a stalwart in the healthcare sector, continues to capture investor interest with its robust financial performance and strategic initiatives in the biopharmaceutical domain...

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: Navigating a Promising 28.52% Upside Potential

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a key player in the biotechnology sector, has drawn significant attention from investors, particularly due to its promising pipeline in treating..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: Exploring a 25.96% Potential Upside Amid Strong Buy Ratings

Merit Medical Systems, Inc. (NASDAQ: MMSI), a prominent player in the healthcare sector, particularly within the medical instruments and supplies industry, offers a compelling investment opportunity..

BrightSpring Health Services (BTSG) Stock Analysis: A Healthcare Powerhouse with Robust Revenue Growth

BrightSpring Health Services, Inc. (NASDAQ: BTSG) has emerged as a formidable player in the healthcare sector, particularly within the health information services industry. Headquartered in Louisville,..

Corcept Therapeutics (CORT) Stock Analysis: Riding High with Strong Analyst Support and Market Cap

Corcept Therapeutics Incorporated (NASDAQ: CORT) is making waves in the biotechnology sector with its innovative approach to developing medications for serious medical conditions. As of today,..

Atrium Therapeutics, Inc. (RNA) Stock Analysis: Exploring an 83% Upside Potential in the RNA Therapeutics Market

For investors seeking opportunities in the burgeoning field of RNA therapeutics, Atrium Therapeutics, Inc. (NASDAQ: RNA) presents a compelling case. With a market capitalization of $233.49..

Axsome Therapeutics (AXSM) Stock Analysis: Unveiling a 13% Potential Upside Amid Robust Revenue Growth

Axsome Therapeutics, Inc. (NASDAQ: AXSM) stands out in the biotech sector with its impressive market capitalization of $12.57 billion. Focused on developing innovative treatments for central..

RadNet, Inc. (RDNT) Investor Outlook: Strong Buy Ratings and 30% Upside Potential

RadNet, Inc. (NASDAQ: RDNT), a prominent player in the healthcare sector specializing in diagnostics and research, is catching the eye of savvy investors with its compelling..

Thermo Fisher Scientific Inc (TMO) Stock Analysis: Evaluating the 13.91% Potential Upside

Thermo Fisher Scientific Inc (TMO), a behemoth in the healthcare sector with a market capitalization of $194.52 billion, stands as a pivotal player in the diagnostics..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: A Strategic Play with 20.83% Potential Upside

Investors eyeing the healthcare sector may find GE HealthCare Technologies Inc. (NYSE: GEHC) to be a compelling prospect. With a market capitalization of $29.82 billion, GE..

Option Care Health, Inc. (OPCH) Stock Analysis: A 30.52% Potential Upside Ignites Investor Interest

Option Care Health, Inc. (NASDAQ: OPCH), a significant player in the healthcare sector with a focus on medical care facilities, offers a compelling opportunity for investors..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Examining the Biotech Firm’s Growth Potential and Market Position

Sarepta Therapeutics, Inc. (SRPT), a prominent player in the biotechnology sector, stands at the forefront of developing transformative therapies for rare diseases. With a market capitalization..

Insulet Corporation (PODD) Investor Outlook: Analyzing a 46% Potential Upside

Insulet Corporation (NASDAQ: PODD), a prominent player in the healthcare sector specializing in medical devices, is capturing the attention of investors with an enticing potential upside..

Encompass Health Corporation (EHC) Stock Analysis: A 31.97% Upside Potential Amid Strong Buy Ratings

Encompass Health Corporation (NYSE: EHC), a leading provider in the healthcare sector, particularly in the field of medical care facilities, offers a promising investment opportunity with..

TransMedics Group, Inc. (TMDX) Stock Analysis: Unveiling 70% Growth Potential with Innovative Organ Care Systems

TransMedics Group, Inc. (NASDAQ: TMDX) is making significant strides in the healthcare sector, specifically in the medical devices industry. With its pioneering Organ Care System (OCS),..

The Ensign Group, Inc. (ENSG) Investor Outlook: Capturing a 31% Potential Upside in Healthcare

The Ensign Group, Inc. (NASDAQ: ENSG) is garnering significant attention from investors, and rightfully so. As a stalwart in the healthcare sector, Ensign operates extensively across..

Elevance Health, Inc. (ELV) Stock Analysis: Navigating a Solid Healthcare Play with a 0.85% Upside Potential

Investors looking for a robust player in the healthcare sector should consider Elevance Health, Inc. (NYSE: ELV), a prominent name in the healthcare plans industry. With..

BioNTech SE (BNTX) Stock Analysis: Exploring a 24.93% Upside Potential Amidst Diverse Clinical Trials

BioNTech SE (NASDAQ: BNTX), a pioneering biotechnology company headquartered in Mainz, Germany, is renowned for its development and commercialization of immunotherapies. With a market cap of..

BioMarin Pharmaceutical Inc. (BMRN): Investor Outlook Reveals 48.92% Potential Upside

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) stands out as a formidable player in the biotechnology sector, focusing on developing therapies for rare diseases. With a market cap..

United Therapeutics Corporation (UTHR) Stock Analysis: A Closer Look at Its 19.67% Potential Upside

For investors eyeing the healthcare sector, United Therapeutics Corporation (NASDAQ: UTHR) presents a compelling opportunity. With a market capitalization of $23.6 billion, this specialty drug manufacturer..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds